Motor neuron disease is a progressive neuro-degenerative disease that causes muscle weakness and gets worse over time.

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

Emerging research highlights the underexplored role of gut neuropeptides in Parkinson’s disease, revealing new connections ...

A Phase I clinical trial, whose results have been published in the prestigious journal Blood, reveals that this new CAR-T30 therapy promotes the expansion of memory T cells, leading to long ...

Researchers have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for ...

A first-of-its-kind study tested the safety of psilocybin on patients with mild to moderate Parkinson’s disease and found ...

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...

View Full Profile. Learn about our Editorial Policies. To create cancer-fighting T cell therapies, scientists use viral vectors to insert a sequence of DNA into a patient’s own T cells, enabling them ...

The results put BlueRock among the leaders in the quest to develop stem cell-based therapies for Parkinson's. Other groups operating in this area include International Stem Cell Corp, which ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD) and also reduces "off" time in patients with moderate to ...